SIX:BION

BB Biotech AG · SIX · Financial Services · CHF · FY for 2025

Figures on this page computed 2026-11-08 12:41 UTC

Last close

n/aCHF

Market data

4.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/mNet marginnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
402.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
3.5%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed

Growth is the furthest below its sector's middle: 0.40 against 0.56 on the market's range.

All from 100

lens 2 of 9

Sales

8.2

2013-12-31 to 2025-12-31100 at the start8.2

Sales: 100.00 on 2013-12-31 to 8.19 on 2025-12-31, down 92%.

Profit

62.0

2013-12-31 to 2025-12-31100 at the start62.0

Profit: 100.00 on 2013-12-31 to 62.04 on 2025-12-31, down 38%.

Shares in issue

96.3

2013-12-31 to 2025-12-31100 at the start96.3

Shares in issue: 100.00 on 2013-12-31 to 96.25 on 2025-12-31, down 4%.

Sales is at 8, Profit is at 62, Shares in issue is at 96, against 100 in 2013.

Sales is at 8, Profit is at 62, Shares in issue is at 96, against 100 in 2013.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1008
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF
Profit, where the first year is 10062
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF
Shares in issue, where the first year is 10096
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF